Spanish researchers to design proteins using AI to make advanced therapies more efficient

by INTEGRA

Researchers have joined forces to design using artificial intelligence and produce next-generation viral particles to be applied in advanced therapies. These particles can be used in immunotherapies, ...

Read more

OneChain Immunotherapeutics achieves FDA Orphan Drug designation for OC-1

by Parc Científic de Barcelona

Spanish biotech OneChain Immunotherapeutics (OCI), has received Orphan Drug designation from the U.S. Food and Drug Administration (FDA)to OC-1, a CAR T therapy against for the treatment of acute lymp...

Read more

The Josep Carreras Institute creates a spin-off to develop therapies for leukaemia based on CAR–T

by Invivo Capital

The Josep Carreras Leukaemia Research Institute, a public centre pertaining to the Generalitat de Catalunya's (Government of Catalonia) CERCA network, has created the OneChain Immunotherapeutics (OCI)...

Read more
Subscribe to Directory
Write an Article

Recent News

¿Por qué no es recomendable llevar la ...

La mejor actitud que podemos adoptar es la de trat...

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

New breakthrough in developing more pers...

by Universitat de Barcelona

The results show that adenocarcinoma exhibits much more active and fun...

Photos Stream